Tag - EBS

Developments

Emergent partners with B.C. to supply NARCAN for take-home program

Emergent BioSolutions (NYSE: EBS) announced that it has partnered with the British Columbia (B.C.) Provincial Health Services Authority (PHSA) to supply NARCAN Nasal Spray for the province’s Take-Home Naloxone Program...

April 10, 2026

Developments

Emergent donates 50,000 smallpox vaccine doses in response to WHO’s mpox declaration

Emergent BioSolutions (NYSE:EBS) announced its pledge to donate 50,000 doses of its ACAM2000 smallpox vaccine through Direct Relief in response to WHO’s declaration that the upsurge of mpox in the Democratic Republic of...

August 20, 2024

Tag - EBS

Emergent partners with B.C. to supply NARCAN for take-home program

Emergent donates 50,000 smallpox vaccine doses in response to WHO’s mpox declaration

Subscribe